TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T39676	Solute carrier family 47 member 1	D00JAU	Irbesartan	Approved	3749	C25H28N6O	428.5	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D00KHM	Pimozide	Approved	16362	C28H29F2N3O	461.5	C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D00SEB	Enalapril	Approved	5388962	C20H28N2O5	376.4	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D02YIZ	Erythromycin	Approved	12560	C37H67NO13	733.9	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D05AHE	Methylergonovine	Approved	8226	C20H25N3O2	339.4	CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C	IC50 > 250000 nM	Non binder
T39676	Solute carrier family 47 member 1	D06NVJ	Nicotinamide	Approved	938	C6H5NO2	123.11	C1=CC(=CN=C1)C(=O)O	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D07GRH	Ciclopirox	Approved	2749	C12H17NO2	207.27	CC1=CC(=O)N(C(=C1)C2CCCCC2)O	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D08QCJ	Thiabendazole	Approved	5430	C10H7N3S	201.25	C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D09FAZ	Azacitidine	Approved	9444	C8H12N4O5	244.2	C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D0DK8V	Cetirizine	Approved	2678	C21H25ClN2O3	388.9	C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D0M4VM	Sulfacetamide	Approved	5320	C8H10N2O3S	214.24	CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D0PQ3G	Furosemide	Approved	3440	C12H11ClN2O5S	330.74	C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D0R1RS	Indomethacin	Approved	3715	C19H16ClNO4	357.8	CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D0TG1H	Diclofenac	Approved	3033	C14H11Cl2NO2	296.1	C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D0X4RN	Lidocaine	Approved	3676	C14H22N2O	234.34	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D0DV8K	Dexamethasone	Phase 3	5743	C22H29FO5	392.5	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D0O2IE	Phenacetin	Withdrawn from market	4754	C10H13NO2	179.22	CCOC1=CC=C(C=C1)NC(=O)C	IC50 > 500000 nM	Non binder
T39676	Solute carrier family 47 member 1	D0D8RC	Metformin	Investigative	4091	C4H11N5	129.16	CN(C)C(=N)N=C(N)N	IC50 = 250000 nM	Non binder